 Radiation-Sensitizing Agents
"Radiation-Sensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
| Descriptor ID |
D011838
|
| MeSH Number(s) |
D27.505.954.600
|
| Concept/Terms |
Radiation-Sensitizing Agents- Radiation-Sensitizing Agents
- Radiation Sensitizers
- Sensitizers, Radiation
- Radiation Sensitizing Agents
- Sensitizing Agents, Radiation
- Radiosensitizing Agents
- Agents, Radiosensitizing
- Radiosensitizing Drugs
- Drugs, Radiosensitizing
- Agents, Radiation-Sensitizing
- Agents, Radiation Sensitizing
- Radiation-Sensitizing Drugs
- Drugs, Radiation-Sensitizing
- Radiation Sensitizing Drugs
Radiation-Sensitizing Effect- Radiation-Sensitizing Effect
- Effect, Radiation-Sensitizing
- Radiation Sensitizing Effect
- Radiosensitizing Effect
- Effect, Radiosensitizing
- Radiosensitizing Effects
- Effects, Radiosensitizing
- Radiation-Sensitizing Effects
- Effects, Radiation-Sensitizing
- Radiation Sensitizing Effects
|
Below are MeSH descriptors whose meaning is more general than "Radiation-Sensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Sensitizing Agents".
This graph shows the total number of publications written about "Radiation-Sensitizing Agents" by people in this website by year, and whether "Radiation-Sensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 0 | 1 | | 1983 | 1 | 0 | 1 | | 1988 | 1 | 0 | 1 | | 1989 | 3 | 0 | 3 | | 1990 | 1 | 0 | 1 | | 1991 | 3 | 0 | 3 | | 1992 | 4 | 0 | 4 | | 1996 | 2 | 0 | 2 | | 1997 | 2 | 1 | 3 | | 1998 | 1 | 2 | 3 | | 1999 | 3 | 1 | 4 | | 2000 | 4 | 0 | 4 | | 2001 | 2 | 0 | 2 | | 2002 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 1 | 2 | | 2007 | 1 | 1 | 2 | | 2008 | 2 | 0 | 2 | | 2009 | 1 | 2 | 3 | | 2010 | 1 | 1 | 2 | | 2011 | 1 | 0 | 1 | | 2012 | 4 | 0 | 4 | | 2013 | 1 | 1 | 2 | | 2014 | 3 | 0 | 3 | | 2015 | 2 | 0 | 2 | | 2016 | 2 | 1 | 3 | | 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Radiation-Sensitizing Agents" by people in Profiles.
-
Murley JS, Miller RC, Senlik RR, Rademaker AW, Grdina DJ. Altered expression of a metformin-mediated radiation response in SA-NH and FSa tumor cells treated under in vitro and in vivo growth conditions. Int J Radiat Biol. 2017 07; 93(7):665-675.
-
Ou SI, Schrock AB, Bocharov EV, Klempner SJ, Haddad CK, Steinecker G, Johnson M, Gitlitz BJ, Chung J, Campregher PV, Ross JS, Stephens PJ, Miller VA, Suh JH, Ali SM, Velcheti V. HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib. J Thorac Oncol. 2017 03; 12(3):446-457.
-
Labay E, Mauceri HJ, Efimova EV, Flor AC, Sutton HG, Kron SJ, Weichselbaum RR. Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers. Oncotarget. 2016 Jun 07; 7(23):33919-33.
-
Hill EJ, Roberts C, Franklin JM, Enescu M, West N, MacGregor TP, Chu KY, Boyle L, Blesing C, Wang LM, Mukherjee S, Anderson EM, Brown G, Dutton S, Love SB, Schnabel JA, Quirke P, Muschel R, McKenna WG, Partridge M, Sharma RA. Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer. Clin Cancer Res. 2016 Apr 15; 22(8):1922-31.
-
Anbalagan S, Biasoli D, Leszczynska KB, Mukherjee S, Hammond EM. In Vitro Radiosensitization of Esophageal Cancer Cells with the Aminopeptidase Inhibitor CHR-2797. Radiat Res. 2015 Sep; 184(3):259-65.
-
DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Villablanca JG, Marachelian A, Matthay KK. Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2015 Jun 15; 21(12):2715-21.
-
Akthar AS, Golden DW, Nanda R, Sharma MR, Te HS, Reddy KG, Zhang X, Malik R. Early and Severe Radiation Esophagitis Associated With Concurrent Sirolimus. J Clin Oncol. 2016 Mar 20; 34(9):e73-5.
-
Lacerda L, Reddy JP, Liu D, Larson R, Li L, Masuda H, Brewer T, Debeb BG, Xu W, Hortobágyi GN, Buchholz TA, Ueno NT, Woodward WA. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med. 2014 Jul; 3(7):849-56.
-
Gabikian P, Tyler BM, Zhang I, Li KW, Brem H, Walter KA. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres. J Neurosurg. 2014 May; 120(5):1078-85.
-
Wang Y, Yuan JL, Zhang YT, Ma JJ, Xu P, Shi CH, Zhang W, Li YM, Fu Q, Zhu GF, Xue W, Lei YH, Gao JY, Wang JY, Shao C, Yi CG, Wang H. Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair. PLoS One. 2013; 8(8):e68784.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|